#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic angiosarcoma Short stature Primary immunodeficiency syndrome Epileptic encephalopathy Narcolepsy Autoimmune haemolytic anaemia Epstein-Barr virus associated lymphoproliferative disorder Partial lipodystrophy Transplant rejection Ductal adenocarcinoma of pancreas Chordoma Synovial sarcoma Trigeminal neuralgia Craniopharyngioma Retinitis pigmentosa More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Pelizaeus-Merzbacher disease – Treatment Adrenogenital syndrome – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Mucopolysaccharidosis I – Treatment Angiosarcoma recurrent – Life with Disease Mucopolysaccharidosis III – Life with Disease Familial haemophagocytic lymphohistiocytosis Myxofibrosarcoma Aicardi-Goutieres syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Crd-4730 Toldc Donepezil Phenylalanine Sodium Chloride Ph. Eur. Tanimilast Beclometasone Dipropionate Prasterone Clopidogrel Hydrogen Sulfate Tenofovir Disoproxil VOTOPLAM Ambroxol Hydrochloride Mometasone Furoate Monohydrate Oxytocin AZD5148 Gremubamab Hypromellose Vemircopan Zidovudine Juniper Berry Oil More therapies…

    Learn about Your Condition

    Asthma Multifocal motor neuropathy Oesophageal cancer metastatic Cervix carcinoma recurrent Follicular lymphoma stage II Skin neoplasm excision Osteosarcoma recurrent Lung neoplasm malignant Infertility male Non-small cell lung cancer Thymoma Frostbite Acute lymphocytic leukaemia Nephrolithiasis Ureteric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Epilepsy

  • Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    France

  • [18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • [18F]CPFPX
    France

  • A study of TRV045 to test its effects on brain cell electrical activity in healthy adult men for epilepsy treatment development

    Not recruiting

    1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • TRV045
    The Netherlands

  • Evaluation of 18F-DPA-714 PET-MRI imaging for locating epileptic focus in patients with drug-resistant partial epilepsy before surgery

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study on the Safety and Effectiveness of Sirolimus for Treating Drug-Resistant Epilepsy in Children with Rare Brain Disorders Linked to mTOR Pathway Activation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cortical dysplasia
    • Epilepsy
    Investigated Drugs:
    • Sirolimus
    Poland

  • Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Perampanel
    Belgium France Germany Spain
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!